What Is Creatine Monohydrate? The Complete Scientific Guide

Chemical Identity: What the Molecule Looks Like

Creatine is a nitrogenous organic acid with the chemical formula C₄H₉N₃O₂. Its molecular weight is 131.13 g/mol. Structurally, it is N-(aminoiminomethyl)-N-methyl glycine, built from a guanidino group bonded to a sarcosine (N-methylglycine) backbone. This guanidino group is the reason creatine can accept and donate a phosphoryl group, a property central to its biological function.

Creatine monohydrate, the supplemental form, is creatine bound to a single water molecule, giving it a molecular weight of 149.15 g/mol. This means creatine monohydrate is approximately 87.9% creatine by mass. The monohydrate form is a white, crystalline powder that is odorless and mildly soluble in water (about 16 g/L at 20 degrees Celsius, rising substantially with temperature). The compound is chemically stable in solid form but degrades slowly to creatinine in acidic aqueous solution, which is one reason it is sold as a dry powder rather than a pre-mixed liquid (Jager et al., 2011).

Despite marketing claims around newer forms (creatine hydrochloride, creatine ethyl ester, buffered creatine), no alternative has demonstrated superior bioavailability or efficacy compared to monohydrate in controlled human trials (Jager et al., 2011). The monohydrate form remains the reference standard in research.

Endogenous Synthesis: Your Body Already Makes Creatine

The human body synthesizes roughly 1 gram of creatine per day through a two-step enzymatic process (Wyss and Kaddurah-Daouk, 2000). This is not a minor metabolic footnote. Creatine synthesis consumes a significant fraction of the body's methyl group supply, accounting for approximately 40% of all S-adenosylmethionine (SAM) usage, more than any other methylation reaction in the body (Brosnan et al., 2011).

Step 1: AGAT Reaction (Kidney)

In the kidneys, the enzyme arginine:glycine amidinotransferase (AGAT) transfers an amidino group from arginine to glycine, producing guanidinoacetate (GAA) and ornithine. This is the rate-limiting step of creatine biosynthesis. AGAT activity is downregulated by dietary creatine intake through a feedback mechanism, meaning exogenous supplementation partially suppresses endogenous production (Walker, 1979).

Step 2: GAMT Reaction (Liver)

Guanidinoacetate then travels via the bloodstream to the liver, where guanidinoacetate N-methyltransferase (GAMT) adds a methyl group from S-adenosylmethionine, producing creatine. The newly synthesized creatine is released into the blood and taken up by target tissues through a sodium- and chloride-dependent creatine transporter (CrT, also called SLC6A8) (Wallimann et al., 2011).

The total creatine pool in a 70 kg adult is approximately 120-140 grams, with roughly 95% stored in skeletal muscle. The remaining 5% is distributed among the brain, kidneys, liver, and testes (Kreider et al., 2017). About two-thirds of intramuscular creatine exists as phosphocreatine (PCr), and one-third as free creatine. Approximately 1.7% of the total creatine pool is irreversibly converted to creatinine each day through a non-enzymatic dehydration reaction and excreted in urine, establishing a daily turnover of about 2 grams that must be replenished through synthesis and diet (Wyss and Kaddurah-Daouk, 2000).

Dietary Sources: How Much You Get from Food

Creatine is found primarily in animal-derived foods. The richest dietary sources are skeletal muscle tissue, which makes intuitive sense given that muscle is where the body stores it.

A typical omnivorous diet provides approximately 1-2 grams of creatine per day, which combines with endogenous synthesis to roughly match the daily turnover rate (Brosnan et al., 2011). Vegetarians and vegans, who receive negligible dietary creatine, rely entirely on endogenous synthesis and consequently tend to have lower baseline muscle creatine stores. Multiple studies have confirmed that vegetarians show approximately 20-30% lower muscle creatine concentrations compared to omnivores, and they also tend to show a greater absolute response to supplementation (Burke et al., 2003).

Cooking degrades some creatine content, particularly methods involving prolonged heat or liquid loss. Roughly 20-30% of the creatine in meat is lost during standard cooking procedures, primarily through conversion to creatinine at elevated temperatures (Harris et al., 1997).

To obtain 5 grams of creatine from food alone, a standard supplemental dose, you would need to consume roughly 1.1 kg (about 2.4 lbs) of raw beef. This quantity makes clear why supplementation, rather than dietary modification, became the practical approach.

The Supplementation Rationale

Under normal dietary conditions, skeletal muscle creatine stores are approximately 60-80% saturated (Harris et al., 1992). That gap between baseline levels and the upper storage limit is the entire premise of creatine supplementation. By increasing oral intake beyond what diet and synthesis provide, it is possible to elevate intramuscular creatine and phosphocreatine concentrations by 20-40%, shifting the energy buffer available during high-intensity work (Hultman et al., 1996).

The magnitude of this increase matters. Harris et al. (1992) demonstrated in their landmark Clinical Science paper that 5 grams of creatine monohydrate taken four times daily for five days increased total muscle creatine by an average of 25 mmol/kg dry muscle. Subsequent research confirmed that a loading protocol of 20 g/day for 5-7 days, followed by a maintenance dose of 3-5 g/day, achieves and sustains near-maximal intramuscular creatine levels (Hultman et al., 1996).

A slower approach also works. Hultman et al. (1996) showed that 3 g/day for 28 days achieves the same final muscle creatine content as the loading protocol, just without the rapid initial increase. Both methods reach the same endpoint, approximately 140-160 mmol/kg dry muscle (up from a baseline of roughly 120 mmol/kg dry muscle), within about four weeks.

The practical performance consequences of this increase are well-documented. Kreider et al. (2017) summarized the literature, noting that creatine supplementation consistently improves maximal strength by 5-10%, work performed during sets of maximal effort by 5-15%, single-effort sprint performance by 1-5%, and repetitive sprint performance by 5-15%. These effect sizes are large by sports science standards, where supplements rarely produce measurable differences in controlled settings.

History of Creatine Research

The compound was first identified in 1832 by the French chemist Michel Eugene Chevreul, who isolated it from meat extract and named it after the Greek word kreas (flesh). Justus von Liebig later confirmed its presence in animal muscle and suggested that wild game contained more creatine than domesticated animals, possibly reflecting activity level differences.

The biological significance of creatine remained obscure until 1927, when Fiske and Subbarow discovered phosphocreatine in muscle tissue, establishing the link between creatine and cellular energy metabolism. This discovery opened the field of bioenergetics research that would eventually explain the phosphocreatine shuttle system (Wallimann et al., 2011).

Modern supplementation research began in 1992 with Roger Harris and colleagues at the Karolinska Institute. Their Clinical Science paper demonstrated for the first time that oral creatine supplementation meaningfully increased muscle creatine content in humans. Within two years, Greenhaff and colleagues at the University of Nottingham published studies showing that elevated muscle creatine improved performance during repeated bouts of maximal exercise (Greenhaff et al., 1993).

By 1996, creatine had become one of the most popular sports supplements in the world. The 1996 Atlanta Olympics saw widespread use among athletes, and media coverage, both enthusiastic and skeptical, pushed creatine into mainstream awareness. The International Society of Sports Nutrition published its first position stand on creatine in 2007 (Buford et al., 2007), and the updated, more comprehensive position stand in 2017 (Kreider et al., 2017) reflects the enormous body of evidence accumulated in the intervening decade.

Safety and Regulatory Status

Creatine monohydrate has been studied in clinical trials involving participants ranging from infants with inborn errors of creatine metabolism to elderly adults with sarcopenia. The ISSN position stand (Kreider et al., 2017) concluded that creatine monohydrate is safe for healthy populations when used at recommended doses. No credible evidence links creatine supplementation to kidney damage, liver dysfunction, or dehydration in healthy individuals, despite persistent popular misconceptions.

Kreider et al. (2017) reviewed the totality of evidence across hundreds of studies and found no clinically significant adverse effects beyond occasional gastrointestinal discomfort at high doses, typically during loading phases. Weight gain of 1-2 kg during the first week of supplementation is common and is primarily attributed to increased intracellular water retention accompanying creatine uptake into muscle cells (Buford et al., 2007).

In the United States, creatine monohydrate is classified as a dietary supplement under the Dietary Supplement Health and Education Act (DSHEA) of 1994. It is not banned by any major sporting organization, including the International Olympic Committee, the World Anti-Doping Agency, the NCAA, and professional sports leagues.

Summary

Creatine monohydrate is a naturally occurring compound synthesized in the body from arginine, glycine, and methionine. Approximately 95% of the body's creatine pool resides in skeletal muscle, where it serves as an immediate energy buffer through the phosphocreatine system. Typical diets and endogenous synthesis leave muscle creatine stores 20-40% below their saturation point. Supplementation fills that gap, producing consistent, measurable improvements in strength and high-intensity exercise performance. After more than three decades of human research, the safety and efficacy profile of creatine monohydrate is among the strongest of any dietary supplement studied.

Bibliography

1. Kreider, R.B., Kalman, D.S., Antonio, J., Ziegenfuss, T.N., Wildman, R., Collins, R., Candow, D.G., Kleiner, S.M., Almada, A.L. and Lopez, H.L. (2017). International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition, 14, 18. doi:10.1186/s12970-017-0173-z
2. Buford, T.W., Kreider, R.B., Stout, J.R., Greenwood, M., Campbell, B., Spano, M., Ziegenfuss, T., Lopez, H., Landis, J. and Antonio, J. (2007). International Society of Sports Nutrition position stand: creatine supplementation and exercise. Journal of the International Society of Sports Nutrition, 4, 6. doi:10.1186/1550-2783-4-6
3. Wallimann, T., Tokarska-Schlattner, M. and Schlattner, U. (2011). The creatine kinase system and pleiotropic effects of creatine. Amino Acids, 40(5), 1271-1296. doi:10.1007/s00726-011-0877-3
4. Wyss, M. and Kaddurah-Daouk, R. (2000). Creatine and creatinine metabolism. Physiological Reviews, 80(3), 1107-1213. doi:10.1152/physrev.2000.80.3.1107
5. Harris, R.C., Soderlund, K. and Hultman, E. (1992). Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clinical Science, 83(3), 367-374. doi:10.1042/cs0830367
6. Hultman, E., Soderlund, K., Timmons, J.A., Cederblad, G. and Greenhaff, P.L. (1996). Muscle creatine loading in men. Journal of Applied Physiology, 81(1), 232-237. doi:10.1152/jappl.1996.81.1.232
7. Greenhaff, P.L., Casey, A., Short, A.H., Harris, R., Soderlund, K. and Hultman, E. (1993). Influence of oral creatine supplementation of muscle torque during repeated bouts of maximal voluntary exercise in man. Clinical Science, 84(5), 565-571. doi:10.1042/cs0840565
8. Jager, R., Purpura, M., Shao, A., Inoue, T. and Kreider, R.B. (2011). Analysis of the efficacy, safety, and regulatory status of novel forms of creatine. Amino Acids, 40(5), 1369-1383. doi:10.1007/s00726-011-0874-6
9. Brosnan, J.T., da Silva, R.P. and Brosnan, M.E. (2011). The metabolic burden of creatine synthesis. Amino Acids, 40(5), 1325-1331. doi:10.1007/s00726-011-0853-y
10. Burke, D.G., Chilibeck, P.D., Parise, G., Candow, D.G., Mahoney, D. and Tarnopolsky, M. (2003). Effect of creatine and weight training on muscle creatine and performance in vegetarians. Medicine and Science in Sports and Exercise, 35(11), 1946-1955. doi:10.1249/01.MSS.0000093614.17517.79
11. Walker, J.B. (1979). Creatine: biosynthesis, regulation, and function. Advances in Enzymology and Related Areas of Molecular Biology, 50, 177-242.
12. Harris, R.C., Jones, G., Hill, C.A., Maycock, M. and Sherwood, R.A. (1997). The creatine content of Creapure and Creatine Monohydrate in meat products and supplements. Proceedings of the Physiological Society.